SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Anaptys Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update

SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. NASDAQ:ANAB, a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza (imsidolimab) with Vanda, today reported financial results for the fiscal first quarter ended September 30, 202…

ANAB

Related stories